Last reviewed · How we verify
NCT07008209
Comparing the Effectiveness of Reappraisal Strategies in Adult Participants
NA trial testing Reconstrual Strategy Training in Emotional Dysregulation in 233 participants. Completed in 10 January 2026.
5 January 2026
Quick facts
| Lead sponsor | Ibn Haldun University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 233 |
| Start date | 21 September 2025 |
| Primary completion | 5 January 2026 |
| Estimated completion | 10 January 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Reconstrual Strategy Training
- Repurposing Strategy Training
- Active Control — full drug profile →
Conditions studied
- Emotional Dysregulation — all drugs for Emotional Dysregulation →
- Anxiety — all drugs for Anxiety →
- Sadness — all drugs for Sadness →
- Anxiety Disorders and Symptoms — all drugs for Anxiety Disorders and Symptoms →
Sponsor
Ibn Haldun University
Who can join
Adults 18 to 30, any sex, with Emotional Dysregulation or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn which reappraisal strategy works better to reduce sadness and anxiety in emerging adults. The main questions it aims to answer are: What is the effect of emotion regulation strategies (reconstrual, repurposing) on short term negative emotions (anxiety, sadness)? Does the effectiveness of these strategies vary depending on the type of emotion (anxiety vs. sadness)? Are reconstrual and repurposing more effective compared to active and passive control conditions? What is the effect of these strategies on short-term positive emotions (e.g., hope, happiness)? Researchers will compare reconstrual and repurposing strategies to see which one is more effective in improving emotional outcomes. Participants will: be randomly assigned to one of eight conditions in a 4 (Regulation Strategy: Reconstrual, Repurposing, Active Control, Passive Control) × 2 (Emotion Type: Sadness vs. Anxiety) factorial design. Complete online tasks and surveys about their emotions
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07008209
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Emotional Dysregulation
Currently open trials in the same condition.
- NCT07040462 — Child-Parent Psychotherapy After the 2023 Kahramanmaraş Earthquake · NA · recruiting
Other Ibn Haldun University trials
Trials by the same sponsor.
- NCT06876103 — Effectiveness of an Online Religiously-integrated Cognitive Behavioral Therapy-based Intervention on Death Anxiety · NA · not yet recruiting
- NCT06945796 — ACT-ED: Accessibility and Feasibility of an Acceptance and Commitment Therapy (ACT)-Based Eating Disorder Prevention Pro · NA · completed
- NCT06213194 — The Effects of Executive Functions and Social Cognition on Mental Health · NA · completed
- NCT07334769 — Religiously Integrated Cognitive Behavioral Therapy · NA · completed
- NCT06758635 — Online Versions of Single Session Virtual Reality (VR) Therapy and EMDR Flash Therapy on the Treatment of Flying Fear · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07008209 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ibn Haldun University
- Last refreshed: 27 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07008209.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing